Attralus, Inc.

Quick facts

Phase 2 pipeline

• 124I-AT-01 · Genetics and Rare Diseases
  124I-AT-01 is a small molecule targeting the lysosomal acid lipase (LAL) enzyme.

Phase 1 pipeline

• 124I-AT03
• AT-02

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Attralus, Inc. portfolio CI brief
• Attralus, Inc. pipeline updates RSS